SCOPUS 정보 검색 플랫폼

Gastroenterology

Volumn 130, Issue 4, 2006, Pages 1352-1354

When Is Too Much Enough?

(1) Mayer, Lloyd a

a MOUNT SINAI MEDICAL CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; IMMUNOSUPPRESSIVE AGENT;

ANAPHYLACTOID PURPURA; APOPTOSIS; CELL GROWTH; CLINICAL TRIAL; CROHN DISEASE; DISEASE ASSOCIATION; DRUG EFFICACY; EDITORIAL; GRAFT VERSUS HOST REACTION; HEPATITIS; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; LEUKOPENIA; NAUSEA; PANCREATITIS; PANCYTOPENIA; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; T LYMPHOCYTE; UNSPECIFIED SIDE EFFECT; VALIDATION PROCESS; DOSE RESPONSE; NOTE;

6-MERCAPTOPURINE; AZATHIOPRINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOSUPPRESSIVE AGENTS;

EID: 33645965292 PISSN: 00165085 EISSN: None Source Type: Journal
DOI: 10.1053/j.gastro.2006.02.045 Document Type: Editorial

Times cited : (3)

References (6)

1
- 0018290191
- National Cooperative Crohn's Disease Study. results of drug treatment
- Summers R.W., Switz D.M., Sessions Jr. J.T., Becktel J.M., Best W.R., Kern Jr. F., and Singleton J.W. National Cooperative Crohn's Disease Study. results of drug treatment. Gastroenterology 77 (1979) 847-869
- (1979) Gastroenterology , vol.77 , pp. 847-869
- Summers, R.W.¹ Switz, D.M.² Sessions Jr., J.T.³ Becktel, J.M.⁴ Best, W.R.⁵ Kern Jr., F.⁶ Singleton, J.W.⁷

2
- 0018888679
- Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study
- Present D.H., Korelitz B.I., Wisch N., Glass J.L., Sachar D.B., and Pasternack B.S. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med 302 (1980) 981-987
- (1980) N Engl J Med , vol.302 , pp. 981-987
- Present, D.H.¹ Korelitz, B.I.² Wisch, N.³ Glass, J.L.⁴ Sachar, D.B.⁵ Pasternack, B.S.⁶

3
- 0028293868
- The role of leukopenia in the 6-mercaptopurine-induced remission of refractory Crohn's disease
- Colonna T., and Korelitz B.I. The role of leukopenia in the 6-mercaptopurine-induced remission of refractory Crohn's disease. Am J Gastroenterol 89 (1994) 362-366
- (1994) Am J Gastroenterol , vol.89 , pp. 362-366
- Colonna, T.¹ Korelitz, B.I.²

4
- 20444483170
- A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine
- Lemann M., Mary J.Y., Colombel J.F., Duclos B., Soule J.C., Lerebours E., Modigliani R., and Bouhnik Y. A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine. Gastroenterology 128 (2005) 1812-1818
- (2005) Gastroenterology , vol.128 , pp. 1812-1818
- Lemann, M.¹ Mary, J.Y.² Colombel, J.F.³ Duclos, B.⁴ Soule, J.C.⁵ Lerebours, E.⁶ Modigliani, R.⁷ Bouhnik, Y.⁸

5
- 0043011380
- Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis
- Warman J.I., Korelitz B.I., Fleisher M.R., and Janardhanam R. Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis. J Clin Gastroenterol 37 (2003) 220-222
- (2003) J Clin Gastroenterol , vol.37 , pp. 220-222
- Warman, J.I.¹ Korelitz, B.I.² Fleisher, M.R.³ Janardhanam, R.⁴

6
- 33646011261
- Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity. a meta-analysis
- Osterman M.T., Kundu R., Lichtenstein G.R., and Lewis J.D. Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity. a meta-analysis. Gastroenterology 130 (2006) 1047-1053
- (2006) Gastroenterology , vol.130 , pp. 1047-1053
- Osterman, M.T.¹ Kundu, R.² Lichtenstein, G.R.³ Lewis, J.D.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.